The Journal of Pediatric Research

Tyrosinemia Type 1 and Reversible Neurogenic Crisis After One Month Interruption of Nitisinone []
. 2017; 4(5): 57-59

Tyrosinemia Type 1 and Reversible Neurogenic Crisis After One Month Interruption of Nitisinone

Havva Yazıcı1, Ebru Canda1, Esra Er1, Mehmet Arda Kılınç2, Sema Kalkan Uçar1, Bülent Karapınar2, Mahmut Çoker1
1Ege University Faculty Of Medicine Department Of Pediatrics, Division Of Metabolism And Nutrition, Izmir,turkey
2Ege University Faculty Of Medicine Department Of Pediatrics,Division Of Pediatric Intensive Care Unit, Izmir, Turkey

Hereditary tyrosinemia type 1 is an autosomal recessive disorder due to deficiency of the enzyme fumarylacetoacetate hydrolase. Liver is the primary organ that is affected and comorbidities involving the renal and neurologic systems and hepatocellular carcinoma can be seen as a long term complication. An effective medical treatment with 2-[2-nitro-4-trifluoromethylbenzoyl]-1,3-cyclohexanedione (NTBC) has been available since 1992. Neurogenic crises do not occur in patients with tyrosinaemia type I treated with NTBC. Here in we report a seven years-old boy with severe neurological crisis after interruption of NTBC treatment including anorexia, vomiting, weakness, hyponatremia, paresthesia and paralysis of the extremities, seizure and arterial hypertension. Re-introduction of NTBC, the patient slowly regained normal neurological functions and normal blood pressure and recovered completely.

Keywords: tyrosinemia type I, neurogenic crises, nitisinone


Havva Yazıcı, Ebru Canda, Esra Er, Mehmet Arda Kılınç, Sema Kalkan Uçar, Bülent Karapınar, Mahmut Çoker. Tyrosinemia Type 1 and Reversible Neurogenic Crisis After One Month Interruption of Nitisinone. . 2017; 4(5): 57-59

Corresponding Author: Havva Yazıcı, Türkiye


TOOLS
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar